Uses of Rocinva 0.75M

Rocinva 0.75M drug with the antibiotic active ingredient spiramycin is indicated by doctors for use in cases of skin, genital and respiratory infections, prevention of meningitis, acute rheumatoid arthritis,... To ensure To be effective when using Rocinva 0.75M, users need to follow the instructions of their doctors, and refer to more information about the uses of Rocinva 0.75M in the following article.

Rocinva 0.75M is an antiparasitic, anti-infective and antiviral or antifungal drug. Rocinva 0.75M has the main ingredient Spiramycin with a concentration of 750000IU. The drug is prepared in the form of oral powder and packed in boxes of 20 packs, each pack of 3g oral powder pills 750000IU.

Indications when using Rocinva 0.75 M:
Infections of the upper and lower respiratory tract, ear, nose and throat or skin and bones, joints, genital tract such as: Pharyngitis, people with acute sinusitis, and superinfection due to bronchitis acute bronchitis, people with exacerbations of chronic bronchitis. Community-acquired pneumonia in people: No risk factors, no severe clinical signs, and lack of clinical factors suggestive of pneumocoques. In the case when atypical pneumonia is suspected, macrolides are used to appoint in any case of severe or mild disease or any locality. Benign skin infections: Impetigo or impetigo of skin disease, impetigo and skin - subcutaneous infections (especially erysipelas). Oral infection. Genital tract infections but not gonorrhea. Prevention of meningococcal meningitis: Spiramycin is not used to treat meningococcal meningitis, but is only indicated for the prevention of patients who have been cured of the disease, before returning. living in a group, and for people who have been in contact with the sick person in the 10 days before being hospitalized. Prevention of relapse of acute rheumatic fever in penicillin-allergic subjects. Toxoplasmosis in pregnant women. Infections caused by susceptible bacteria. Contraindications: People with a history of hypersensitivity to spiramycin and erythromycin.

Rocinva 0.75M is in powder form and should be taken orally.
Patients should always consult with their doctor or pharmacist before deciding to take medicine.

In infants and children: 150000 to 300000 IU/kg/day, divided into 2 to 3 times. Children from 10 to 20 kg: Use 150000 UI to 300000 IU/day, divided into 2 to 3 times. For the prevention of meningococcal meningitis in children 75,000 IU/kg for 12 hours, for 5 days. Patients taking spiramycin must follow the entire course of treatment. Dosage and potency of spiramycin are expressed in international units (units) Adults: Use 1.5 to 3 million units, 3 times in 24 hours Prophylaxis of congenital Toxoplasmosis during pregnancy: 9 million units per day, divided into several doses for 3 weeks, repeat dose every 2 weeks. Used in combination or alternately with pyrimethamine and sulfonamide regimens, better results may be obtained.

Ideally, the patient is still taking the medicine exactly as prescribed by the doctor. Taking the medicine at the right time will ensure the best effect of the medicine. Usually can take the drug 1 to 2 hours from the time ordered by the doctor, should not take the dose of Rocinva 0.75M when the time is too far for the next dose.

In the case of an overdose of Rocinva 0.75M that requires emergency care, family members need to bring a prescription or a bottle of medicine that the patient has taken. In addition, family members also need to know the patient's height and weight to notify the doctor.

Patients need to fully inform the specialist doctor, or pharmacist about their medical condition such as: current medical condition, or medical history, allergies, pregnancy or breastfeeding, .. .. Patients should carefully read the instructions for use before using the drug Be careful when using the drug with the elderly because the sensitivity in these people to the drug may be greater than that of normal adults. The drug can cross the placenta, but does not cause complications when used in pregnant patients. The drug is excreted in breast milk in high concentrations, so patients need to stop breastfeeding when taking Rocinva 0.75M.

Common side effects include: Nausea or vomiting, diarrhea and indigestion. Uncommon: Fatigue, or epistaxis, and sweating, or chest tightness, acute colitis, skin rash, or exanthema and urticaria. Rare: anaphylactic shock or superinfection due to long-term use of oral spiramycin.

What drugs can interact with Rocinva 0.75M? Tell your doctor or pharmacist of all prescription and over-the-counter medicines, vitamins, minerals, herbal products and medicines prescribed by other doctors that you are taking. Always consult your doctor. Can Rocinva 0.75M interact with any food or drink? Food, alcohol, and tobacco can interact with certain medications. Please consult your doctor about taking medicine with food, alcohol and tobacco

The shelf life of Rocinva 0.75M is 36 months from the date of manufacture. Store Rocinva 0.75M in a cool, dry place, at a temperature not exceeding 30°C, in the original packaging and protected from light. Keep out of reach of children and pets. Carefully read the instructions for storage of Rocinva 0.75M medicine listed on the package and the instruction sheet for use of the drug. Check the expiry date of the medicine. When not using Rocinva 0.75M, it should be collected and handled according to the instructions of the manufacturer or the person in charge of medicine.